Academic Journals Database
Disseminating quality controlled scientific knowledge

Rationale of Drug Safety: Pharmacovigilance and Pharmacoeconomics

ADD TO MY LIST
 
Author(s): V. Subhahini*, Vinay Alaparthi* and B.Suresh

Journal: Journal of Pharmacy Research
ISSN 0974-6943

Volume: 4;
Issue: 9;
Start page: 3159;
Date: 2011;
Original page

Keywords: PV-pharmacovigilance | ADR - adverse-drug-reaction | PMS-post-market surveillance | PE-pharmacoeconomic | PVPE- pharmacovigilance | pharmacoeconomic.

ABSTRACT
The discipline of PV has developed considerably since 1972 WHO technical report, it remains a dynamic clinical and scientific discipline. It has been essential tomeet the challenges of the increasing range and potency of medicines (including vaccines), which carry with them an inevitable and sometimes unpredictablepotential for harm. Measures for unsafe use, negative outcomes of medication are usually used before measures of safe and effective use. Product-defect and ADRreporting systems comprise the basic elements of PV worldwide. Issues addressed in PV specification are evidence-based justification and PMS of individual drugsafety. To evaluate the outcomes of PV, PE study is one of the best tools. The rationale of drug safety can be assessed using the combination of PVPE studies.

Tango Rapperswil
Tango Rapperswil

     Save time & money - Smart Internet Solutions